Cascade Partners served as exclusive advisor to Compass Healthcare in the successful sale of Lansing Institute of Urology to The Cancer & Hematology Centers, a partner of OneOncology.

The Goal

Compass Healthcare, referred to Cascade Partners by former a former client, sought to divest its cancer treatment and related clinical operations to ensure the long-term success of the practice while allowing the organization to focus resources on its core specialties.

The Cascade Advantage

Cascade Partners guided Compass Healthcare through a complex transaction process that required carving out two clinical practices to integrate with a strategic partner. The Cascade team worked closely with both the buyer and the seller to navigate numerous challenges and complexities by leveraging creative problem-solving, stakeholder education, and collaborative deal structuring.

The Result

The transaction resulted in a successful transition and integration of two clinical practices with The Cancer & Hematology Centers, strengthening the community’s oncology and broader patient care capabilities. The deal enabled Compass Healthcare to concentrate resources on its core focus areas while ensuring continuity of high-quality cancer care for patients in the region.

Through strategic negotiation and innovative solutions, Cascade Partners facilitated a transaction that met the needs of all stakeholders, owners, employees, and the community.

Cascade Partners served as the exclusive financial advisor to Compass Healthcare.

Learn about the companion acquisition of Compass Cancer Center here.